With continued use and a commitment to healthy habits, many patients achieve: Significant weight loss over several months
This can cause symptoms such as tremors, restlessness, agitation, dizziness, and loss of coordination
Only the treating clinician can determine whether the expected benefit outweighs the risk
These drugs work in very different ways but share a common goal: to help people reduce and manage their weight
Using pharmacological agents with cardiovascular and renal benefits, including reninangiotensin system inhibitors and sodium-glucose cotransporter-2 inhibitors, is paramount
To enhance the pharmacological properties of the ruthenium catalyst, provide cancer selectivity for the treatment, and enable the treatment of challenging hypoxic tumors, the metal complexes were covalently conjugated to the side chains of polymers with a carbon fluorinated moiety that could co-deliver oxygen to the tumor